Novartis (NYSE: NVS) reported Q2 EPS of $1.30, $0.01 better than the analyst estimate of $1.29. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Earnings Guidance Hot Guidance